You are viewing: North America Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The North America Biopreservation Market was valued at $1764.2 Million in 2024 and projected to reach to $2852.9 Million by 2029, representing a compound annual growth rate of 10.1%. North America's biopreservation market is poised for sustained expansion, driven by increasing investments in cell and gene therapy research, growing demand for organ transplantation solutions, and the proliferation of biobanking facilities across the United States and Canada.

North America Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Biopreservation Market Trends and Insights

  • This expansion reflects North America's leadership in advanced healthcare infrastructure, regenerative medicine adoption, and cell therapy development.
  • North America's strong regulatory framework and significant investment in biotechnology research are driving demand for sophisticated preservation technologies across clinical and research applications. The North America biopreservation market benefits from a mature healthcare ecosystem with substantial funding for stem cell research, organ transplantation programs, and personalized medicine initiatives.
  • North America's pharmaceutical and biotech sectors are increasingly integrating biopreservation solutions into their workflows, supporting the market's 10.1% compound annual growth rate through 2029.
  • North America's emphasis on quality control, compliance standards, and long-term sample viability continues to position the region as a critical hub for biopreservation innovation and adoption..

Key Market Statistics

  • CAGR (2024-2029) 10.1% CAGR
  • Market Size, 2024 ~USD 1764.2 Million
  • Forecast, 2029 ~USD 2852.9 Million
  • Geography North America

North America Biopreservation Market Overview

Market Leadership Position :

North America commands the largest share of the global biopreservation market, driven by advanced healthcare infrastructure, substantial R&D investments, and early adoption of cutting-edge preservation technologies across the region.

Regenerative Medicine Hub :

The region is a global epicenter for regenerative medicine and cell therapy development, with numerous clinical trials and FDA-approved therapies creating sustained demand for sophisticated biopreservation solutions.

Robust Regulatory Framework :

North America's stringent regulatory standards and established guidelines from the FDA and Health Canada ensure high-quality biopreservation practices, attracting investment and fostering market confidence among stakeholders.

Strong CAGR Trajectory :

With a 10.1% CAGR from 2024 to 2029, North America's biopreservation market is expanding faster than the global average of 9.8%, reflecting accelerating adoption in clinical and research applications.

North America Biopreservation Market Dynamics

  • The region's leadership in biotechnology innovation and favorable reimbursement policies continue to accelerate market penetration.
  • Emerging applications in personalized medicine and regenerative therapies are expected to unlock new revenue streams and drive market diversification throughout the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • North America's biopreservation market will grow from $1,764.2M (2024) to $2,852.9M (2029) at a 10.1% CAGR.
    • North America leads in regenerative medicine and cell therapy adoption, driving biopreservation technology demand.
    • North America's stringent regulatory standards and compliance requirements support premium biopreservation solution adoption.
    • North America's robust biotech funding and research infrastructure accelerate innovation in preservation methodologies.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    North America Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    Target Audience

    • Biopreservation Equipment Manufacturers : Manufacturers need North America-specific demand forecasts, regulatory requirements, and customer adoption patterns to optimize product development and distribution strategies in this high-value market.
    • Cell & Gene Therapy Companies : Therapy developers require detailed market insights on biopreservation infrastructure availability, reimbursement landscapes, and competitive offerings to support clinical trial planning and commercialization.
    • Hospital & Research Institution Administrators : Healthcare leaders need market data to justify capital investments in biopreservation facilities, benchmark against peer institutions, and align procurement strategies with regional growth trends.
    • Investment & Private Equity Firms : Investors require comprehensive North America market analysis to identify acquisition targets, assess portfolio company growth potential, and evaluate emerging biopreservation technology opportunities.
    • Regulatory & Compliance Consultants : Consultants need region-specific regulatory insights and market dynamics to advise clients on North American market entry, compliance strategies, and competitive positioning in biopreservation.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 1604.4 Million · 9.1% wtd CAGR ·
    Asia Pacific
    ~USD 1661.4 Million · 11% wtd CAGR ·
    Latin America
    ~USD 418.5 Million · 8.7% wtd CAGR ·
    Middle East & Africa
    ~USD 334 Million · 8.1% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 1234 Million
    CanadaUSD 110 Million

    Country market size visualization

    US
    USD 1234 Million
    Canada
    USD 110 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($1,764.2M in 2024) with detailed 5-year projections, enabling accurate budgeting and strategic planning for regional expansion.
    • Country-Level Breakdown : Access granular data for the US and Canada markets separately, allowing targeted go-to-market strategies and competitive positioning within each North American submarket.
    • Growth Driver Analysis : Understand the specific factors propelling North America's 10.1% CAGR, including regulatory tailwinds, clinical adoption rates, and investment trends unique to the region.
    • Competitive Landscape Intelligence : Identify leading biopreservation providers, emerging players, and market consolidation trends specific to North America's healthcare and biotechnology ecosystem.
    • Strategic Investment Insights : Leverage North America-focused market intelligence to identify high-growth segments, partnership opportunities, and acquisition targets within regenerative medicine and cell therapy sectors.

    Frequently asked questions

    What is the current size of North America's biopreservation market?

    North America's biopreservation market was valued at $1,764.2 million in 2024 and is expected to reach $2,852.9 million by 2029.

    What is the projected growth rate for North America's biopreservation market?

    North America's biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2029.

    What factors are driving growth in North America's biopreservation market?

    North America's biopreservation market growth is driven by advances in regenerative medicine, increased cell therapy adoption, robust biotech funding, and stringent regulatory compliance requirements.

    Which applications dominate North America's biopreservation market?

    North America's biopreservation market is dominated by applications in stem cell research, organ transplantation, cell therapy manufacturing, and personalized medicine initiatives.

    How does North America's biopreservation market compare to global trends?

    North America's biopreservation market grows at 10.1% CAGR, slightly outpacing the global market's 9.8% CAGR, reflecting the region's advanced healthcare infrastructure and research investment.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status